HIV control biomarkers: a European study for long-term viral control
Part of Infections clinical trials.
This study looks for markers in the blood that help some people with HIV stay virus-free without medication for a long time. If you have controlled your HIV without drugs for at least 6 months, or are interested in pausing your medication to see if you can control the virus, this study may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have HIV and have had a high viral load (more than 1000 copies of HIV per mL of blood) before starting HIV medications.
- After stopping HIV medications, you must have had your viral load stay at 400 or lower at least twice, with tests at least 6 months apart, and no more than one test above 400 during that time.
- If you have been part of a study that paused your HIV medications (called an ATI or MAP study), you may qualify if you meet the same viral control criteria as above, even if the pause was shorter than 6 months.
- Alternatively, if you have never tried stopping your HIV medications and you are currently on treatment with a viral load under 50, you can join as a control.
- You cannot participate if you have previously said you do not want your medical data used for research.
- No specific age or health restrictions are mentioned, but you must be able to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with HIV on antiretroviral therapy still have small amounts of virus in their blood, while others achieve undetectable levels. Researchers will compare the two groups to understand the virus and immune system, which may help improve future treatments.
This study looks at the hidden virus and immune system in people living with HIV who can control the virus without medication or after certain treatments. It aims to understand why some people control HIV better, which could lead to new treatments.
This study looks at whether some people with HIV can keep the virus controlled even if they temporarily stop HIV medicines (an “analytic treatment interruption”). If you qualify, it may help researchers learn what it would take for an HIV cure.
This trial tests whether a combination of powerful antibodies (bNAbs) can help control HIV after stopping standard HIV treatment. Participants will pause their daily HIV medications while receiving these antibodies, and doctors will closely monitor their immune system and virus levels. It's for people who are already well-controlled on HIV treatment and have participated in a specific earlier study.
This Phase 2 study uses special scans (PET/CT) and tissue sampling (biopsy) to learn what is happening in the body while people with HIV take a planned break from antiretroviral therapy (ART) for up to 90 days. It may help researchers find better ways to control HIV without ongoing treatment, though joining involves careful monitoring during the pause.
This trial tests whether you can safely stop your HIV medication for a while if your immune system has specific markers that might help control the virus. The goal is to see if a treatment pause could be an option for people like you.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.